Round 1


In Round 1, Queensland Genomics overarching logic and design was based on:

  • The conduct of a series of Clinical Demonstration Projects over three 18-month funding rounds;

  • The concurrent establishment of five Capability-building Workstreams over three 18-month phases; and

  • A clinically-led and patient-centred translational research and implementation focus.

The Round 1 granting process occurred in late 2016, with successful projects awarded in April 2017.  Round 1 clinical and capability projects began in September 2017, and were completed in early 2019.

The Round 2 investment decision making process occurred in 2018, with successful projects announced in early 2019.